Bellevue Life Sciences Acquisition Corp. (BLAC)

Bellevue Life Sciences Acquisition will go public soon, but the exact IPO date is still unknown.
IPO Price
Shares Offered
Deal Size
Chart not available yet
Data will show when the stock starts trading.
Market Cap 85.73M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 8.57M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About BLAC

Bellevue Life Sciences Acquisition is a newly organized blank check company incorporated in Delaware and formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. We intend to focus our search on companies in the healthcare industry, more specifically in the biotechnology sector. We are focused on companies developing the next generation of biologics which include therapeutic antibodies, engineered... [Read more]

Industry Shell Companies
Sector Financials
Founded 2020
Country United States
Stock Exchange NASDAQ
Ticker Symbol BLAC
Full Company Profile


Biotech SPAC Bellevue Life Sciences Acquisition files for a $60 million IPO

Bellevue Life Sciences Acquisition, a blank check company backed by Bellevue Capital Management targeting the biotech sector, filed on Friday with the SEC to raise up to $60 million in an initial publ...

10 months ago - Renaissance Capital

Bellevue Life Sciences Acquisition IPO Registration Document (S-1)

Bellevue Life Sciences Acquisition has filed to go public with an IPO on the NASDAQ.

10 months ago - SEC